CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +1,453 | $55.83 | $81K | 4,122,706 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +1,894 | $56.89 | $108K | 4,124,600 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +295 | $57.63 | $17K | 4,124,895 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +1,302 | $58.98 | $77K | 4,126,197 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +417 | $60.21 | $25K | 4,126,614 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +136 | $62.20 | $8K | 4,126,750 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +139 | $63.85 | $9K | 4,126,889 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +95 | $64.44 | $6K | 4,126,984 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +16 | $65.32 | $1K | 4,127,000 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +15 | $70.62 | $1K | 4,127,015 |
| 2023-06-26 | Chen Bihua 10% owner | Purchase | +85 | $72.46 | $6K | 4,127,100 |
| 2023-06-08 | Sturge Simon Director | Grant or award · Option to Buy | +11,297 | 11,297 | ||
| 2023-06-08 | Xavier Ramnik Director | Grant or award · Option to Buy | +11,297 | 11,297 | ||
| 2023-06-08 | Loy Spike Director | Grant or award · Option to Buy | +11,297 | 11,297 | ||
| 2023-06-08 | Moukheibir Catherine Director | Grant or award · Option to Buy | +11,297 | 11,297 | ||
| 2023-06-08 | Phillips Andrew John Director | Grant or award · Option to Buy | +11,297 | 11,297 | ||
| 2023-06-08 | BVF PARTNERS L P/IL Director | Grant or award · Option to Buy | +11,297 | 11,297 | ||
| 2023-04-05 | Bodenstedt Matthias Chief Financial Officer | Conversion | +410,796 | 410,796 | ||
| 2023-04-05 | Bodenstedt Matthias Chief Financial Officer | Returned to the company | −410,796 | 0 | ||
| 2023-04-05 | Bodenstedt Matthias Chief Financial Officer | Conversion | +147,135 | 557,931 |
Page 8 of 10 · 184 trades